Tailored Interventions to Improve Hypertension Management After Stroke or Transient Ischemic Attack (TIA) (TIMSII)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine the effectiveness of interventions to improve adherence to medication and healthier lifestyle choices on blood pressure over a 6 month period in a group of people at high risk for recurrent stroke events. The participants have already had a stroke or TIA, and have uncontrolled blood pressure, as well as problems with memory and problem-solving, or miss taking medications, or who do not believe in the effectiveness of their medications. Interventions focus on motivational interviewing, adherence counseling with memory cuing, and self-monitoring of blood pressure.
| Condition | Intervention |
|---|---|
|
Blood Pressure |
Behavioral: lifestyle counseling, home blood pressure monitoring |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Tailored Interventions to Improve Hypertension Management After Stroke or TIA |
- blood pressure [ Time Frame: 6 months from baseline testing ] [ Designated as safety issue: No ]
- self-efficacy rating [ Time Frame: 6 months from baseline ] [ Designated as safety issue: No ]
| Enrollment: | 56 |
| Study Start Date: | March 2010 |
| Study Completion Date: | October 2011 |
| Primary Completion Date: | October 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Adherence counseling |
Behavioral: lifestyle counseling, home blood pressure monitoring
monthly telephone counseling over 6 months for intervention group no health provider initiated contact for control group
Other Name: motivational interviewing
|
| Usual care |
Behavioral: lifestyle counseling, home blood pressure monitoring
monthly telephone counseling over 6 months for intervention group no health provider initiated contact for control group
Other Name: motivational interviewing
|
Detailed Description:
- randomized, controlled trial at 4 sites
- measurement of blood pressure, missed pills, self-efficacy rating at baseline and 6 months
- contacting family pharmacists to evaluate prescription renewal patterns at baseline and 6 months
Eligibility| Ages Eligible for Study: | 19 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
clients recruited from Stroke Prevention Clinics in Ontario with diagnosis of Stroke or TIA, Hypertension, and cognitive deficits as indicated by MoCA score < 26, self-efficacy rating < 100%, and self-report of missed pills; English speaking; able to give informed consent; older than 18 years of age
Inclusion Criteria:
- diagnosis of stroke or TIA
- hypertension
- Montreal Cognitive Assessment score less than 26
- self report of missed pills
- self-efficacy rating less than 100%
Exclusion Criteria:
- inability to give informed consent
- 18 years of age or younger
Contacts and Locations| Canada, Ontario | |
| Royal Victoria Hospital | |
| Barrie, Ontario, Canada | |
| Hamilton General Hospital, 237 Barton St East | |
| Hamilton, Ontario, Canada, L8L 2X2 | |
| Lakeridge Health Centre | |
| Oshawa, Ontario, Canada, L1G 2B9 | |
More Information
No publications provided
| Responsible Party: | Gail MacKenzie, Clinical Nurse Specialist, Stroke Prevention Clinic, Hamilton Health Sciences, General Site, McMaster University |
| ClinicalTrials.gov Identifier: | NCT01038375 History of Changes |
| Other Study ID Numbers: | OSN0912-000106 |
| Study First Received: | December 22, 2009 |
| Last Updated: | April 30, 2012 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by McMaster University:
|
hypertension stroke adherence |
Additional relevant MeSH terms:
|
Ischemic Attack, Transient Hypertension Stroke Brain Ischemia Cerebrovascular Disorders |
Brain Diseases Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on June 18, 2013